-
Entity
-
Individual
-
Location
-
C/O Onyx Pharmaceuticals, Inc., 249 East Grand Ave., South San Francisco, CA
-
Summary
-
The estimated net worth of Helen Torley is at least $47.4M dollars as of February 18, 2025. Helen Torley is the PRESIDENT AND CEO, Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $46.7M. Helen Torley is the Director of QUEST DIAGNOSTICS INC and owns shares of QUEST DIAGNOSTICS INC (DGX) stock worth about $769K.